Bayer Signs US$1.7 B Deal with Bicycle Therapeutics for Cancer Radiopharmaceuticals
By Amit Kaushik
Pharma Deals Review: Vol 2023 Issue 5 (Table of Contents)
Published: 19 May-2023
DOI: 10.3833/pdr.v2023.i5.2785 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to bolster its radiopharmaceutical portfolio, Bayer has agreed to pay US$45 M upfront to collaborate with Bicycle Therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018